426
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness

, & ORCID Icon
Article: 29 | Received 10 Nov 2020, Accepted 01 Dec 2020, Published online: 04 Dec 2023

Figures & data

Fig. 1 Key components of the AU Model Law

Fig. 1 Key components of the AU Model Law

Fig. 2 The historical context of the African Medicines Agency

Fig. 2 The historical context of the African Medicines Agency

Fig. 3 The proposed structure of the AMA. The proposed governance structure of AMA includes Member States, a Board with strong African government and technical representation, key stakeholders and a Secretariat led by the Head of AMA. AMA’s Board will be responsible for strategic oversight and direction, financial performance and accounts to the Member States through the AUC. The Secretariat will be responsible for operational performance, strategy/business plan implementation, as well as coordination/facilitation of medicines regulatory activities and harmonisation. The AMA’s structure intends to ensure the maintenance of a lean staff and the use of both internal staff and experts from participating NMRAs. The role of key staff will therefore be the coordination of AMA’s activities. The European Medicines Agency (EMA) and WHO PQTm have used similar approaches. The Head of AMA will be supported by a resource mobilisation team, an advocacy and partnership team, a legal services team and a technical capacity team [Citation11]

Fig. 3 The proposed structure of the AMA. The proposed governance structure of AMA includes Member States, a Board with strong African government and technical representation, key stakeholders and a Secretariat led by the Head of AMA. AMA’s Board will be responsible for strategic oversight and direction, financial performance and accounts to the Member States through the AUC. The Secretariat will be responsible for operational performance, strategy/business plan implementation, as well as coordination/facilitation of medicines regulatory activities and harmonisation. The AMA’s structure intends to ensure the maintenance of a lean staff and the use of both internal staff and experts from participating NMRAs. The role of key staff will therefore be the coordination of AMA’s activities. The European Medicines Agency (EMA) and WHO PQTm have used similar approaches. The Head of AMA will be supported by a resource mobilisation team, an advocacy and partnership team, a legal services team and a technical capacity team [Citation11]

Table 1 Level of implementation of regulatory functions at national, regional and continental level [Citation11]